Aminoglycoside treatment II. Dosage regimens in Danish medical departments;Aminoglykosidbehandling II. Dosisregimer pa intern-medicinske afdelinger i Danmark

Ugeskrift for Laeger

Volumn 160, Issue 1, 1997, Pages 50-52

  Lund, Eva S ^a   Eliasen, Per ^a,b   Wandall, Erik P ^a   Hansen, Erik Feldager ^a   Lomholdt, Jens Due ^a   Friis, Henrik M U ^a  

^a Medicinsk Afd Klinisk M ^*

^b Medicinsk Afdeling   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; GENTAMICIN; NETILMICIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; DRUG INDUCED DISEASE; DRUG MONITORING; DRUG SAFETY; HOSPITAL DEPARTMENT; HUMAN; KIDNEY FUNCTION; NEPHROTOXICITY; OTOTOXICITY; DENMARK; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG UTILIZATION; INTERNAL MEDICINE; QUESTIONNAIRE; STATISTICS;

ANTI-BACTERIAL AGENTS; DENMARK; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG UTILIZATION; GENTAMICINS; HOSPITAL DEPARTMENTS; HUMANS; INTERNAL MEDICINE; QUESTIONNAIRES;

EID: 0031590659     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Luft FC. The nephrotoxic potential of netilmicin as determined in a rat model. Scand J Infect Dis Suppl 1980; 23: 82-80.
2. Wersäll J. The ototoxic potential of netilmicin compared with amikacin. An animal study in Guinea pigs. Scand J Infect Dis Suppl 1980; 23. 104-13.
3. Hansen M, Achen F, Carstensen C, Coolidge J, Dahlager J, Frimodt-Møller N et al Once-versus thrice-daily dosing of netilmicin in immunocompromized patients: a randomized, controlled study of efficacy and safety J Drug Dev 1988; 1 (suppl 3): 119-24.
4. Harada Y. Comparative study on the physiological and morphological effects of netilmicin and other aminoglycosides on the inner ear. J Drug Dev 1988; 1 (suppl 3): 109-13.
5. De Broe ME, Guiliano RA, Verpooten GA. Insight into the renal handling of aminoglycosides: a guideline for prevention of nephrotoxicity. J Drug Dev 1988; 1 (suppl 3): 83-92.
6. Sturm AW. Netilmicin in the treatment of Gram-negative bacteremia: single daily versus multiple daily dosage. J Infect Dis 1989; 159: 931-7.
7. Nordström L, Ringberg H, Cronberg S, Tjernstrom O, Walder M. Does administration of an aminoglycoside in a single daily dose affect its efficacy and toxicity? J Antimicrob Chemother 1990; 25: 159-73.
8. Prins JM, Büller HR, Kuijper EJ, Tange RA, Speelman P. Once versus thrice daily gentamicin in patients with serious infections. Lancet 1993; 341: 335-9.
9. Justesen T. Aminoglycosider - kan vi gøre det bedre? Ugeskr Læger 1993; 155: 1435.
10. Knudsen LM, Frimodt-Møller N, Hansen M, Hippe E. Aminoglykosidadministration én gang i døgnet. En terapeutisk og økonomisk gevinst. Ugeskr Læger 1993, 155: 1436-41.
11. Smaill F. Commentary: single daily dose of aminoglycoside is the preferred mode of administration. BMJ 1996; 312: 344-5.